Sophie Visvikis-Siest

researcher

Sophie Visvikis-Siest is …
instance of (P31):
humanQ5

External links are
P5243Canal-U person IDvisvikis-siest-sophie-101311532
P269IdRef ID101311532
P2798Loop ID645703
P496ORCID iD0000-0001-8104-8425
P1053ResearcherIDH-2324-2014
P214VIAF ID206059711

P185doctoral studentAbdelsalam SalehQ57074470
Said El ShamiehQ57552233
Ndeye Coumba NdiayeQ79298942
Marc RancierQ84976271
P69educated atFrench National Institute of Health and Medical ResearchQ1474517
P108employerFrench National Institute of Health and Medical ResearchQ1474517
P735given name???Q14942517
???Q14942517
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

doctoral advisor (P184)
Q57074470Abdelsalam Saleh
Q84976271Marc Rancier
Q79298942Ndeye Coumba Ndiaye
Q57552233Said El Shamieh

author (P50)
Q922638804th ESPT summer school: precision medicine and personalised health
Q572493368th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3–5 October 2016
Q57996196A Multilocus Genotyping Assay for Cardiovascular Disease
Q49170154A comparison of lifestyle, genetic, bioclinical and biochemical variables of offspring with and without family histories of premature coronary heart disease: the experience of the European Atherosclerosis Research Studies.
Q28740367A genome-wide association search for type 2 diabetes genes in African Americans
Q43894795A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism
Q35024990A multilocus genotyping assay for candidate markers of cardiovascular disease risk
Q47890685A new single nucleotide polymorphism genotyping method based on gap ligase chain reaction and a microsphere detection assay
Q30559038A parametric copula model for analysis of familial binary data
Q45285740A prospective study on the prevalence of metabolic syndrome among healthy french families: two cardiovascular risk factors (HDL cholesterol and tumor necrosis factor-alpha) are revealed in the offspring of parents with metabolic syndrome
Q67887100A rapid and reliable method for direct genotyping of codon 360 in the human apolipoprotein A-IV gene
Q34897205A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk
Q43749369APOC3, CETP, beta-fibrinogen and MTHFR are genetic determinants of carotid intim-media thickness (Stanislas cohort)
Q43612626APOC3, CETP, fibrinogen, and MTHFR are genetic determinants of carotid intima-media thickness in healthy men (the Stanislas cohort).
Q43267776Adipokine expression in adipose tissue and in peripheral blood mononuclear cells in children Correlation with BMI and fatty acid content
Q73827606Age- and sex-related reference values for serum adhesion molecule concentrations in healthy individuals: intercellular adhesion molecule-1 and E-, P-, and L-selectin
Q45155423Age- and sex-related reference values for serum insulin concentration and its biological determinants in a French healthy population. The STANISLAS cohort
Q31160120An analysis of genotype effects and their interactions by using the apolipoprotein E polymorphism and longitudinal data
Q57997232An insertion deletion polymorphism in the signal peptide of the human apolipoprotein B gene
Q51498161Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB-455 G/A polymorphism.
Q35799595Angiogenesis related genes NOS3, CD14, MMP3 and IL4R are associated to VEGF gene expression and circulating levels in healthy adults
Q51039519Apo B signal peptide insertion/deletion polymorphism is involved in postprandial lipoparticles' responses.
Q41193905Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors.
Q48494055Apolipoprotein AIV codon 360 mutation increases with human aging and is not associated with Alzheimer's disease.
Q57997059Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls
Q57996401Apolipoprotein E Level in Cerebrospinal Fluid Increases With Aging
Q43915269Apolipoprotein E activates Akt pathway in neuro-2a in an isoform-specific manner
Q73048445Apolipoprotein E genotype epsilon 4/epsilon 2 in the STANISLAS Cohort Study--dominance of the epsilon 2 allele?
Q43862818Apolipoprotein E in apolipoprotein B (apo B)- and non-apo B-containing lipoproteins in 3523 participants in the Stanislas cohort: biological variation and genotype-specific reference limits.
Q73171412Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group
Q43878391Apolipoprotein E polymorphism in a Moroccan population: allele frequency and relation to plasma lipid concentrations
Q34093070Apolipoprotein E polymorphisms and concentration in chronic diseases and drug responses
Q57995959Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project
Q48484420Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry
Q61654935Apolipoprotein E-epsilon 4 allele and Alzheimer's disease
Q50867083Apolipoprotein E4, lipoprotein lipase C447 and angiotensin-I converting enzyme deletion alleles were not associated with increased wall thickness of carotid and femoral arteries in healthy subjects from the Stanislas cohort.
Q40456376Apolipoprotein E: an important gene and protein to follow in laboratory medicine
Q43545528Apolipoproteins E and C-III in apo B- and non-apo B-containing lipoproteins in middle-aged women from the Stanislas cohort: effect of oral contraceptive use and common apolipoprotein E polymorphism.
Q29547208Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
Q44562478Association between Gly241Arg ICAM-1 gene polymorphism and serum sICAM-1 concentration in the Stanislas cohort
Q51541675Association between angiotensin II type 1 receptor gene polymorphism and metabolic syndrome in a young female Iranian population.
Q46089026Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the STANISLAS cohort
Q57996267Association of Apolipoprotein E Polymorphism and Concentration with Serum Lipids and Apo-lipoprotein Level in the Chinese fromShanghai
Q53203000Association of apolipoprotein E allele epsilon 4 with late-onset sporadic Alzheimer's disease.
Q57994961Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort
Q35043398Association of genetic Loci with glucose levels in childhood and adolescence: a meta-analysis of over 6,000 children
Q46061354Association of human cathelicidin (hCAP-18/LL-37) gene expression with cardiovascular disease risk factors
Q42791922Association study of gene polymorphisms involved in vascular alterations in elderly hypertensives with subjective memory complaints
Q73070461Associations of apolipoprotein E concentration and polymorphism with lipids and apolipoprotein levels in Chinese from Beijing and Shanghai
Q44809955Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population
Q37880880Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy
Q44308570Biological and genetic determinants of serum apoC-III concentration: reference limits from the Stanislas Cohort.
Q54381132Biological and genetic factors associated with ABCB1 and pregnane-X-receptor expressions in peripheral blood mononuclear cells in the STANISLAS cohort.
Q57611853Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort
Q46901979Biological determinants of and reference values for plasma interleukin-8, monocyte chemoattractant protein-1, epidermal growth factor, and vascular endothelial growth factor: Results from the STANISLAS cohort
Q44798939Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study
Q67282550Biological factors affecting concentrations of serum LpAI lipoprotein particles in serum, and determination of reference limits
Q50888264Biological variations and genetic reference values for apolipoprotein E serum concentrations: results from the STANISLAS cohort study.
Q45137480Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort
Q43600213Candidate gene polymorphisms in cardiovascular disease: a comparative study of frequencies between a French and an Italian population.
Q57996091Capillary electrophoretic analysis of recombinant human apolipoprotein E
Q53424328Capillary isotachophoresis study of lipoprotein network sensitive to apolipoprotein E phenotype. 1. ApoE distribution between lipoproteins.
Q37889427Cardiovascular diseases and genome-wide association studies
Q37491073Cardiovascular diseases-related GNB3 C825T polymorphism has a significant sex-specific effect on serum soluble E-selectin levels
Q46733368Cardiovascular risk-associated allele frequencies for 15 genes in healthy elderly French and Chinese
Q53324676Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease.
Q43974372Changes in serum apolipoprotein and lipoprotein profile after alcohol withdrawal: effect of apolipoprotein E polymorphism
Q44535752Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation
Q30809437Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels.
Q44301379Charge-based heterogeneity of human plasma lipoproteins at hypertriglyceridemia: capillary isotachophoresis study.
Q35108524Childhood obesity is associated with shorter leukocyte telomere length
Q57994495Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarin
Q57994506Clinical necessity of partitioning of human plasma haptoglobin reference intervals by recently-discovered rs2000999
Q51575482Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort.
Q57611895Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms
Q45750225Conference Scene: Systems biology and personalized health science and translation
Q53088955Conference scene: pharmacogenomics: from cell to clinic (part 2).
Q42619582Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study
Q47361495Cytochromes P450 are differently expressed in normal and varicose human saphenous veins: linkage with varicosis
Q77525617DNA extraction and stability for epidemiological studies
Q72407552DNA polymorphisms of human apolipoprotein A-IV gene: frequency and effects on lipid, lipoprotein and apolipoprotein levels in a French population
Q47197889DNA polymorphisms of the apoprotein B gene are associated with altered plasma lipoprotein concentrations but not with perceived risk of cardiovascular disease: European Atherosclerosis Research Study
Q43815848Dairy product consumption, calcium intakes, and metabolic syndrome-related factors over 5 years in the STANISLAS study
Q53234663Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease.
Q56893651Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis
Q57994984Determination of ABCB1 polymorphisms and haplotypes frequencies in a French population
Q79186938Different genes and polymorphisms affecting high-density lipoprotein cholesterol levels in Greek familial hypercholesterolemia patients
Q37515592Drug metabolizing enzymes and transporters mRNA in peripheral blood mononuclear cells of healthy subjects: biological variations and importance of pre-analytical steps
Q48232841Effect of LSR polymorphism on blood lipid levels and age-specific epistatic interaction with the APOE common polymorphism.
Q50115571Effect of SLCO1B1 gene polymorphisms and vitamin D on statin-induced myopathy
Q40438217Effect of acute and chronic psychostimulant drugs on redox status, AP-1 activation and pro-enkephalin mRNA in the human astrocyte-like U373 MG cells
Q51560929Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: the EARS II study. European Atherosclerosis Research Study.
Q44531633Effect of six candidate genes on early aging in a French population
Q50998343Effects of apo B and apo E gene polymorphisms on lipid and apolipoprotein concentrations after a test meal.
Q43923209Environmental and genetic determinants of intima-media thickness of the carotid artery
Q36760692Enzymes and pharmacogenetics of cardiovascular drugs
Q64101383Epigenome-Wide Association Study (EWAS) of Blood Lipids in Healthy Population from STANISLAS Family Study (SFS)
Q96170253Epigenome-wide association study in healthy individuals identifies significant associations with DNA methylation and PBMC extract VEGF-A concentration
Q56879645Erratum: New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
Q58209872Ethnic differences in the linkage disequilibrium and distribution of single-nucleotide polymorphisms in 35 candidate genes for cardiovascular diseases
Q70331352Evaluation of lipoproteins and apolipoproteins in serum of a Tangier patient by micro-scale two-dimensional electrophoresis
Q35196218Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels
Q57994633Expression of inflammatory molecules and associations with BMI in children
Q30683122Extension of variance components approach to incorporate temporal trends and longitudinal pedigree data analysis.
Q44816656Factors of variation and reference intervals for serum GST activity: the Stanislas cohort study
Q41234829Familial resemblance of plasma apolipoprotein B: the Nancy study
Q73245641Familial studies on the genetics of cardiovascular diseases: the Stanislas cohort
Q35042612Family studies: their role in the evaluation of genetic cardiovascular risk factors.
Q57996565Family study of lipoprotein lipase gene polymorphisms and plasma triglyceride levels
Q51021100Family study of lipoprotein lipase gene polymorphisms and plasma triglyceride levels.
Q44545654Family study of the relationship between height and cardiovascular risk factors in the STANISLAS cohort.
Q57994846Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a gender-dependant way: the Stanislas study
Q73010208Frequencies of five genetic polymorphisms in coronarographed patients and effects on lipid levels in a supposedly healthy population
Q68882682Frequency and effects of the apolipoprotein A-IV polymorphism
Q57995016From human genetic variations to prediction of risks and responses to drugs and the environment
Q33188294From transcriptomics to bibliomics
Q28729063Functional epistatic interaction between rs6046G>A in F7 and rs5355C>T in SELE modifies systolic blood pressure levels
Q57994734Functional genomics towards personalized healthcare
Q57994588Functional genomics towards personalized healthcare and systems medicine
Q57994862Genetic Polymorphism of CYP2C19 Gene in the Stanislas Cohort. A link with Inflammation
Q73199102Genetic and environmental influences on left ventricular mass. A family study
Q38046386Genetic biomarkers of hypertension and future challenges integrating epigenomics
Q33341793Genetic determinants of blood pressure regulation
Q41496109Genetic determinants of leucocyte telomere length in children: a neglected and challenging field
Q44838781Genetic influences on blood pressure within the Stanislas Cohort
Q43803761Genetic influences on lipid metabolism trait variability within the Stanislas Cohort
Q36419139Genetic variants predisposing to cardiovascular disease
Q57996321Genetics strongly determines the wall thickness of the left and right carotid arteries
Q58618794Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders
Q28307044Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations
Q36435865Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans
Q43949756Glutathione S-transferases genetic polymorphisms and human diseases: overview of epidemiological studies
Q34578402Growing significance of myeloperoxidase in non-infectious diseases.
Q57995053Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: association with apolipoprotein E alleles
Q36854315High sensitivity of laser-induced fluorescence detection in capillary gel electrophoresis for accurate apolipoprotein E genotyping
Q74599356High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity
Q71568778High-resolution separation of PCR product and gene diagnosis by Capillary gel electrophoresis
Q44359835Homo- and hetero-complexes of exchangeable apolipoproteins in solution and in lipid-bound form.
Q57995824Human Apolipoprotein E concentration in response to diseases and therapeutic treatments
Q28240999Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders
Q54398144Human formyl peptide receptor 1 C32T SNP interacts with age and is associated with blood pressure levels.
Q44651976IL-6, TNF-alpha and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort.
Q40097383IL6R haplotype rs4845625*T/rs4537545*C is a risk factor for simultaneously high CRP, LDL and ApoB levels
Q35354678Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels
Q35882777Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis.
Q70289118Immunochemical study of the plasma low and high density lipoproteins in Tangier disease
Q48388034Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients
Q37139179Influence of genetic variations on levels of inflammatory markers of healthy subjects at baseline and one week after clopidogrel therapy; results of a preliminary study
Q36277978Inter-individual variation of inflammatory markers of cardiovascular risks and diseases
Q57995217Interaction between CYP1A1 T3801C and AHR G1661A polymorphisms according to smoking status on blood pressure in the Stanislas cohort
Q50852418Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure.
Q57995947LEPR gene polymorphisms: associations with overweight, fat mass and response to diet in women
Q46576906Leptin expression in Peripheral Blood Mononuclear Cells (PBMCs) is related with blood pressure variability
Q40508503Lipid and lipoprotein genetic variability: an important contribution from the French health examination centers.
Q73333477Lipoprotein lipase (C/G)447 polymorphism and blood pressure in the Stanislas Cohort
Q57995070Meeting Report: From human genetic variations to prediction of risks and responses to drugs and the environment
Q50911423Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort.
Q43135056Metabolic syndrome-related composite factors over 5 years in the STANISLAS family study: genetic heritability and common environmental influences
Q34212342Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus
Q44171936Molecular pharmacophore determination of lipid lowering drugs with the receptor mapping method
Q43663634Multilocus approach to cardiovascular risk
Q41094614Multivariate genetic analysis of high density lipoprotein particles
Q53256331Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study.
Q44485540Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome
Q83835656Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia
Q28270700New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
Q51020366Newly identified synergy between clopidogrel and calcium-channel blockers for blood pressure regulation possibly involves CYP2C19 rs4244285.
Q36122410Novel association approach for variable number tandem repeats (VNTRs) identifies DOCK5 as a susceptibility gene for severe obesity
Q34221038Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals
Q61942928O97 Des variants du gène MTNR1B du récepteur 2 à la mélatonine augmentent la glycémie et le risque de DT2 : un lien entre le rythme circadien et le diabète ?
Q57996367Objectives, Design and Recruitment of a Familial and Longitudinal Cohort for Studying Gene-Environment Interactions in the Field of Cardiovascular Risk: The Stanislas Cohort
Q44441372PON1-192 Phenotype and Genotype Assessments in 918 Subjects of the Stanislas Cohort Study
Q57994776Parental precocious influences on offspring cardiovascular risk markers: an exploratory study in the STANISLAS Cohort
Q92660694Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population
Q64354468Personalised Medicine: The Odyssey from Hope to Practice
Q57994790Personalized therapy and pharmacogenomics: future perspective
Q38766498Pharmacogenomic challenges in cardiovascular diseases: examples of drugs and considerations for future integration in clinical practice
Q57995102Pharmacogenomics and antihypertensive drugs: a path toward personalized medicine
Q36326419Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers
Q28171051Pharmacogenomics and drug response in cardiovascular disorders
Q35127795Pharmacogenomics of Drugs Affecting the Cardiovascular System
Q53090390Pharmacogenomics: from cell to clinic (Part 1).
Q44981833Phenotypic sensitivity to activated protein C in healthy families: importance of genetic components and environmental factors
Q35949808Plasma VEGF-related polymorphisms are implied in autoimmune thyroid diseases
Q70320463Plasma apolipoproteins in Tangier disease, as studied with two-dimensional electrophoresis
Q49658063Pleiotropy of ABO gene: correlation of rs644234 with E-selectin and lipid levels
Q54649601Polymorphism of the 5-HT2A receptor gene and food intakes in children and adolescents: the Stanislas Family Study.
Q83999277Polymorphisms associated with apolipoprotein B levels in Greek patients with familial hypercholesterolemia
Q33292739Preanalytical variations of proteic biomarkers
Q43785238Protein-lipid interactions in reconstituted high density lipoproteins: apolipoprotein and cholesterol influence.
Q44205301Rapid spectrophotometric method for serum glutathione S-transferases activity.
Q74301567Relationship between E-selectin L/F554 polymorphism and blood pressure in the Stanislas cohort
Q30655179Sample size calculations for classical association and TDT-type methods using family data
Q57611892Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms
Q44384141Serum total antioxidant status, erythrocyte superoxide dismutase and whole-blood glutathione peroxidase activities in the Stanislas cohort: influencing factors and reference intervals
Q46011141Sex-dependent associations of leptin with metabolic syndrome-related variables: the Stanislas study.
Q68037513Signal peptide-length variation in human apolipoprotein B gene. Molecular characteristics and association with plasma glucose levels
Q35934127Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies
Q72021049Sources of variability of human plasma apolipoprotein A-IV levels and relationships with lipid metabolism
Q37067797Statins as effectors of key activities involved in apoE-dependent VLDL metabolism: review and hypothesis
Q57996039Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E
Q24600520Study of the sequence tagged site (STS) in the beginning of human apo A4 gene region
Q45171999Synthesis and in vitro antioxidant activity of glycyrrhetinic acid derivatives tested with the cytochrome P450/NADPH system
Q46319580Systems medicine, personalized health and therapy
Q96117594TERC Variants Associated with Short Leukocyte Telomeres: Implication of Higher Early Life Leukocyte Telomere Attrition as Assessed by the Blood-and-Muscle Model
Q41236879TREM-1 SNP rs2234246 regulates TREM-1 protein and mRNA levels and is associated with plasma levels of L-selectin
Q60958793The 9th Santorini Conference: Systems Medicine, Personalised Health and Therapy. "The Odyssey from Hope to Practice", Santorini, Greece, 30 September⁻3 October 2018
Q44838786The Leu554Phe polymorphism in the E-selectin gene is associated with blood pressure in overweight people
Q37207278The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases
Q46520615The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype
Q72060165The effect of variation in the apolipoprotein B gene on plasmid lipid and apolipoprotein B levels. I. A likelihood-based approach to cladistic analysis
Q71981668The frequency of the factor V gene R506Q mutation varies between regions of France
Q47756265The future of telomere length in personalized medicine
Q46813897The lipoprotein lipase serine 447 stop polymorphism is associated with altered serum carotenoid concentrations in the Stanislas Family Study
Q55017597The polymorphism rs6918289 located in the downstream region of the TREM2 gene is associated with TNF-α levels and IMT-F.
Q54244113The role of genetics in defining reference values and health status.
Q52592956The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in
Q46947785Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects
Q40522986Two polymorphisms for amino acid substitutions in the APOA4 gene
Q69266475Two-dimensional electrophoresis of plasma proteins and high density lipoproteins during inflammation
Q91588366VEGF-A is associated with early degenerative changes in cartilage and subchondral bone
Q68369749Variations in apolipoproteins serum amyloid A, A-I, A-II, and C-III in severely head-injured patients
Q46772934Visfatin, low-grade inflammation and body mass index (BMI).
Q47748241Visfatin: the link between inflammation and childhood obesity
Q34584614What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?
Q57995681Which Are the best Tools for Specific Clinical Application (Chips, Multiplex, Mass Spec Profile, etc.)?
Q57995694Which, and How Limited Number of Polymorphisms Should Be Selected per Disease, Risk Assessment, Health Profile or Biological System?
Q109309676Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
Q64914847[Alzheimer disease: hypotheses implicating apolipoproteins E].
Q68148035[Application of bidimensional electrophoresis in the determination of genetic variants]
Q74563923[Association between E-selectin Leu554Phe polymorphism and blood pressure in the Stanislas cohort]

Search more.